Annual Report

Overview

The report presents ACME's FY2024-2025 performance, including BDT 35,936.86 million in revenue and its sustainability-focused operating initiatives. It highlights commercial production of three API products and the launch of the first veterinary vaccine, LSD-NDOLL. Sustainability disclosures cover the Triple Bottom Line, employee welfare, water recycling, environmental initiatives, and the Zero Waste Farming: More from Less agri-system.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2024-2025
Period: 1 July 2024 – 30 June 2025
Publication date: 30 November 2025
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services